跳至主要内容
临床试验/ISRCTN69836999
ISRCTN69836999已完成未知

Efficacy and safety of whole-body chlorhexidine gluconate (CHG) cleansing in reducing bacterial skin colonisation of hospitalised neonates: A pilot trial

St George's, University of London0 个研究点目标入组 208 人开始时间: 2020年6月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
208

研究概览

简要总结

2023 Abstract results in https://escmid.reg.key4events.com/AbstractList.aspx?e=17&preview=1&aig=-1&ai=13126 Presented at ECCMID (added 18/04/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38426071/ (added 01/03/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 1-6 days (post-natally) at enrolment
  • 2. Gestational age =28 weeks at birth
  • 3. Birth weight =1000g and <2000g (or current weight if unknown)
  • 4. Parental consent
  • 5. Parent’s willingness to avoid routine use of emollients other than those indicated by the randomised allocation

排除标准

  • 1. Poor skin condition (skin score of 2 or more in any of three domains) at the time of enrolment
  • 2. Known congenital or acquired skin disorder or defect at time of enrolment
  • 3. Anticipated length of hospital stay <7 days
  • 4. Chlorhexidine or emollient application determined inappropriate in the opinion of the enrolling clinician

研究者

相似试验